C. Gauglhofer

发表

FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities

S. Spiegl-Kreinecker, T. Mohr, J. Pichler, 2008, Oncogene.

Up‐regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis

T. Mohr, W. Berger, R. Schulte‐Hermann, 2011, Hepatology.

Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.

C. Pirker, T. Mohr, W. Berger, 2014, Carcinogenesis.

NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.

R. Schulte‐Hermann, W. Mikulits, D. Kandioler, 2009, Cancer research.

Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF 1 A

R. Schulte‐Hermann, W. Mikulits, D. Kandioler, 2008 .

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

W. Berger, B. Grasl-Kraupp, M. Grusch, 2008, Molecular Cancer Therapeutics.

epidermal growth factor receptor inhibition cancer cells : therapeutic implications and synergism with contribute to the malignant phenotype of non-small cell lung Fibroblast growth factor receptor-mediated signals

W. Berger, B. Grasl-Kraupp, M. Grusch, 2008 .

Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis.

W. Berger, A. Baierl, B. Grasl-Kraupp, 2012, Cancer research.

Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration

S. Spiegl-Kreinecker, W. Berger, B. Grasl-Kraupp, 2010, British Journal of Cancer.